| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.038 | 0.8 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.8 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.041 | 0.8 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |